GlaxoSmithKline PLC GSK

May 16 (Reuters) - Two drugs being developed by GlaxoSmithKline Plc - each designed to block different pathways used by cancer cells - have been shown in a small clinical trial to curb melanoma with fewer side effects than current therapies.

… Holdings LTD ADR (RHHBY), $120 billion (mega cap, Switzerland) Merck & Co ( MRK ), $116 billion (mega cap, U.S.) GlaxoSmithKline PLC ADR ( GSK ), $116 billion (mega cap, U.K.) Abbott Labs ( ABT ), $98 Complete Story »

… Buffett's 10 Best Yielding Stock Holdings . They are: Company Market Cap ($B) Yield (as of 3/1/2012) GlaxoSmithKline plc ( GSK ): Discovery, development, manufacture, and marketing of pharmaceutical products. $113.32 5.02 …

By EP Vantage : Comments made by some of AstraZeneca 's ( AZN ) biggest investors in the wake of the announcement Thursday that chief executive David Brennan will be departing are likely to have had many a pharma executive shifting uncomfortably. The Financial Times among others reported that ...

… GlaxoSmithKline made a $13 offer for the company. Shares ended the day 98% higher to close at $14.17 The Deal GlaxoSmithKline Plc ( GSK ) made an all cash offer of $13 per share to the board of directors of Human Genome Sciences on the 11th …

… high yield big pharmaceutical stocks at WallStreetNewsNetwork.com, there are ten pharmaceutical stocks with yields of 4.0% or more, with two stocks paying more than 5%. One example is GlaxoSmithKline plc ( GSK ), the Complete Story »

March 30 (Reuters) - Moody's disclosures on credit ratings of GlaxoSmithKline Plc

By Dutch Trader : One of my first articles on Seeking Alpha was A Closer Look at Renhuang Pharmaceuticals , and back then the stock was around $1.86. China Botanic Pharmaceutical ( CBP ), as the company is now known, currently trades around $0.80, about a dollar less than in October 2010. Revenues